BRIANA HANEY: Open Payments
NPI 1821652413 · WEBSTER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,807 in 66 payments from 16 companies in 2025. Trend: 2023 $873 · 2024 $1,141 · 2025 $1,807
Food & beverage: $1,807
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 9 | $360 |
| Amgen Inc. | 13 | $257 |
| SCPHARMACEUTICALS INC. | 8 | $252 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $166 |
| Novartis Pharmaceuticals Corporation | 7 | $154 |
| Medtronic, Inc. | 1 | $110 |
| AstraZeneca Pharmaceuticals LP | 6 | $109 |
| AngioDynamics, Inc. | 3 | $83 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $60 |
| Esperion Therapeutics, Inc. | 3 | $59 |
Products named: CARDIOMEMS, REPATHA, FUROSCIX, Kerendia, LEQVIO, VENASEAL, FARXIGA, AURYON LASER SYSTEM 100-120 VAC.
Industry payments across TX — which companies pay providers there.
